Видео с ютуба Tdxd

TDXD For Improved PFS in HER2 Low Metastatic Breast Cancer

Effectiveness of TDXD vs. Sacituzumab for ER+ Breast Cancer | Jane Meisel, MD | ASCO22 Updates

DESTINY-04: HER2 1+/FISH- Metastatic Breast Cancer TDXD Treatment | Jane Meisel, MD | ASCO22 Updates

New TDXD Regimen Eliminates Induction and Maintenance Phases for Breast Cancer Treatment

TDXd for Brain Metastases: The Baseball Slugger

Трастузумаб дерукстекан при раке молочной железы | NEJM

New Trial Tests TDXD for Prolonged Breast Cancer Control

New Data Suggests TDXD as Second Line for Breast Cancer with Brain Metastasis

Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancers │ Pharmacology

Trastuzumab Deruxtecan Impresses in HER2+ Breast Cancer Trial

Detecting and Managing T-DXd–Related Interstitial Lung Disease: The Five “S” Rules

New Hope for HER2 Low Breast Cancer Patients - ASCO DBO6 Trial Results

Unparalleled Brain Metastasis Effectiveness of TDXD in HER2+ Breast Cancer

DESTINY-Breast12 Intracranial activity of TDXd in HER2-positive Patients with brain metastases

New Study Shows TDXD with Pertuzumab Superior to Cleopatra Regimen for Breast Cancer Treatment

TDXD Breast Cancer Treatment: Longer Duration, Better Results?